Back

Design and rationale of the PERSEVERE study: a randomized controlled trial of large-bore mechanical thrombectomy versus the standard of care for high-risk pulmonary embolism

30 August 2025 (17:00 - 17:10)
Organised by: Logo
Congress Presentation Part of: Precision diagnostics to guide precision therapy Trial Design ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Nicolas Meneveau

Regional University Hospital Jean Minjoz, Besancon (France)

4 More presentations in this session

Presentation thumbnail
Patient-specific Display of Treatment Information and Adherence to Clinical Practice Guideline Recommendations (PEER-APP): a dual center, blinded randomized controlled trial
Doctor C. Scherer (Munich, DE)
Abstract Slides Video
Presentation thumbnail
The inclusion of cancer in heart failure risk assessment tool for patients with type-2 diabetes mellitus: a precision medicine approach
Doctor N. Kaur (Glasgow, GB)
Abstract Slides Video
Presentation thumbnail
Non-contact biometric system for detecting hypertension and diabetes using artificial intelligence and spectral imaging
Ms R. Uchida (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Simplified regimen for the management of hypertension with telemedicine and blood pressure self-monitoring (SIMPLE): an open-label, multicenter, randomized controlled trial
Professor Y. Zhang (Shanghai, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Precision diagnostics to guide precision therapy
Video

The Event

Event poster

ESC Congress 2025

30 August 2025 17:00 CET
You may be interested in
thumbnail
Congress Presentation
Q&A
thumbnail
Congress Presentation
Insights from STORM PE: first RCT in aspiration thrombectomy vs. standard of care
thumbnail
Congress Presentation
Latest research on large-bore thrombectomy: an evidence-based therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources